By leveraging Italian and Austrian excellence in genetics, clinics and biotechnology, the p-care cross-border collaboration takes aim at cancer drug resistance and develops innovative strategies for re-sensitizing tumors to therapies and spurring the immune system to fight cancer.
138 people in all were connected and followed the event from the crossborder regions involved in the project.
The first p-care workshop on precision cancer medicine will be held online today, starting at 11:00.